OmicVision Biosciences ApS is a Danish APS based in København Ø, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 17 employees and reported revenue of 3,6 mio. kr. in its latest annual filing.
3,6 mio. kr.
+133% vs 2024
-4,4 mio. kr.
-47% vs 2024
Solidity ratio Equity ÷ Total assets × 100 2024 2025
Liquidity ratio Current assets ÷ Short-term debt 2024 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2024 2025
EBITDA — year on year DKK millions 0M -1M -2M -4M -5M 2024: -4M -4M 2024 2025: -4M (0% vs 2024) -4M 0% 2025
Key figures Annual report 2025 Revenue 3,6 mio. kr. +133% EBITDA -4,4 mio. kr. -26% Net profit -4,4 mio. kr. -47% Total assets 12,3 mio. kr. +125% Equity 0,1 mio. kr. -97% Employees 17 —
Legal name
OmicVision Biosciences ApS
Founded
1 September 2023 · 2 years
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden.
Company purpose
Selskabets formål er at drive bioteknologisk forskning og udvikling af diagnostik til kræft og andre sygdomme, samt hermed beslægtet virksomhed.
(no translation available)
Email
iummat@omicvision.com
Website
www.omicvision.com
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), OmicVision Biosciences ApS reported a gross profit of 3,6 mio. kr., an increase of 133% on the year before. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of 4,4 mio. kr., and the EBITDA margin stood at -123.6%.
At the end of 2025, equity financed 1% of the balance sheet, and current assets covered short-term debt 4.7 times. OmicVision Biosciences ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of OmicVision Biosciences ApS? OmicVision Biosciences ApS is registered with CVR / Virk under CVR 44285584.
What is the revenue of OmicVision Biosciences ApS? OmicVision Biosciences ApS reported revenue of 3,6 mio. kr. in 2025.
How many employees does OmicVision Biosciences ApS have? OmicVision Biosciences ApS employs 17 people as of the latest annual report.
Who is the CEO of OmicVision Biosciences ApS? Ishani Tara Ummat is the CEO of OmicVision Biosciences ApS, in role since 2024.
Who is the chairman of OmicVision Biosciences ApS? Ole Vorm chairs the board of OmicVision Biosciences ApS.
Where is OmicVision Biosciences ApS headquartered? OmicVision Biosciences ApS's registered address is Ryesgade 113.
More on OmicVision Biosciences ApS 